1-27551305-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001371928.1(AHDC1):​c.811C>G​(p.Pro271Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000545 in 1,611,608 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P271L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0030 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00029 ( 2 hom. )

Consequence

AHDC1
NM_001371928.1 missense

Scores

2
2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.78

Publications

1 publications found
Variant links:
Genes affected
AHDC1 (HGNC:25230): (AT-hook DNA binding motif containing 1) This gene encodes a protein containing two AT-hooks, which likely function in DNA binding. Mutations in this gene were found in individuals with Xia-Gibbs syndrome. [provided by RefSeq, Jun 2014]
AHDC1 Gene-Disease associations (from GenCC):
  • AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Orphanet, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035629869).
BP6
Variant 1-27551305-G-C is Benign according to our data. Variant chr1-27551305-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00301 (458/152260) while in subpopulation AFR AF = 0.0108 (447/41562). AF 95% confidence interval is 0.00993. There are 3 homozygotes in GnomAd4. There are 213 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 458 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AHDC1NM_001371928.1 linkc.811C>G p.Pro271Ala missense_variant Exon 8 of 9 ENST00000673934.1 NP_001358857.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AHDC1ENST00000673934.1 linkc.811C>G p.Pro271Ala missense_variant Exon 8 of 9 NM_001371928.1 ENSP00000501218.1

Frequencies

GnomAD3 genomes
AF:
0.00300
AC:
457
AN:
152142
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0108
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000783
AC:
192
AN:
245138
AF XY:
0.000538
show subpopulations
Gnomad AFR exome
AF:
0.0108
Gnomad AMR exome
AF:
0.000756
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000271
Gnomad OTH exome
AF:
0.000167
GnomAD4 exome
AF:
0.000288
AC:
420
AN:
1459348
Hom.:
2
Cov.:
57
AF XY:
0.000256
AC XY:
186
AN XY:
725978
show subpopulations
African (AFR)
AF:
0.00995
AC:
333
AN:
33464
American (AMR)
AF:
0.000739
AC:
33
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26086
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39668
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86196
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51860
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000180
AC:
20
AN:
1111322
Other (OTH)
AF:
0.000514
AC:
31
AN:
60320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00301
AC:
458
AN:
152260
Hom.:
3
Cov.:
33
AF XY:
0.00286
AC XY:
213
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0108
AC:
447
AN:
41562
American (AMR)
AF:
0.000392
AC:
6
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67990
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
23
47
70
94
117
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000893
Hom.:
1
Bravo
AF:
0.00352
ESP6500AA
AF:
0.0114
AC:
49
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00111
AC:
134
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AHDC1: BS1, BS2 -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 15, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 15, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.033
T;T;T;T;T
Eigen
Benign
-0.19
Eigen_PC
Benign
0.0020
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.73
.;.;T;.;.
MetaRNN
Benign
0.0036
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.55
N;N;N;N;N
PhyloP100
1.8
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.31
N;.;N;.;.
REVEL
Benign
0.076
Sift
Pathogenic
0.0
D;.;D;.;.
Sift4G
Benign
0.38
T;.;T;.;.
Polyphen
0.0010
B;B;B;B;B
Vest4
0.28
MVP
0.10
MPC
1.3
ClinPred
0.066
T
GERP RS
4.3
Varity_R
0.091
gMVP
0.28
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200660997; hg19: chr1-27877816; COSMIC: COSV106083286; COSMIC: COSV106083286; API